Verastem, Inc.   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Needham MA United States (2010)

Organization Overview

First Clinical Trial
2010
NCT00666926
First Marketed Drug
2018
duvelisib (copiktra)
First NDA Approval
2018
duvelisib (copiktra)
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Verastem, Inc. | VERASTEM INC | Verastem Oncology